Weekly highlight of top insider buys: Tiffany & Co. (TIF, Financial), Plains Exploration and Production Company (PXP, Financial), Cleco Corp. (CNL, Financial), Seattle Genetics Inc. (SGEN, Financial), and GeoEye Inc. (GEOY, Financial).
Director of Tiffany & Co., Lawrence K Fish, bought 4,000 shares during the past week at an average price of $48.25.
Tiffany & Co. operates jewelry and specialty retail stores and manufactures products through its subsidiary corporations. Tiffany & Co. has a market cap of $6 billion; its shares were traded at around $48.25 with a P/E ratio of 23.8 and P/S ratio of 2.2. The dividend yield of Tiffany & Co. stocks is 1.7%. Tiffany & Co. had an annual average earning growth of 6.9% over the past 10 years. GuruFocus rated Tiffany & Co. the business predictability rank of 4-star.
On March 22, Tiffany & Co. reported that worldwide sales rose 17% in its fourth quarter ended January 31, 2010. This increase reflected broad-based growth in the Americas, Asia-Pacific and European regions. Net earnings from continuing operations were $1.09 per diluted share in the quarter. Full year sales declined 5% to $2.7 billion and net earnings from continuing operations increased 15% to $2.12 per diluted share (earnings in both years included nonrecurring charges
Tiffany & Co. is in the portfolios of four Gurus: Kenneth Fisher, Brian Rogers, John Rogers, and Ron Baron.
Last week, Sell:: CHAIRMAN AND CEO Michael Joseph Kowalski sold 100,000 shares of TIF stock. Sell:: EXEC. VICE PRESIDENT AND CFO James N Fernandez sold shares in January. Last week, Buy:: Director Lawrence K Fish bought 2,000 shares; Sell:: SENIOR VICE PRESIDENT John S Petterson, Sell:: SENIOR VICE PRESIDENT Patrick B Dorsey, and Sell:: SENIOR VICE PRESIDENT Caroline D Naggiar sold shares in March.
Plains Exploration & Production Company (PXP): Chairman of the Board James C Flores Bought 200,000 Shares
Chairman of the Board of Plains Exploration & Production Company, James C Flores, bought 200,000 shares on 3/31/10 at an average price of $30.92.
Plains Exploration & Production Company is an independent oil and gas company primarily engaged in the activities of acquiring, developing, exploring and producing oil and gas properties primarily in the United States. Plains Exploration & Production Company has a market cap of $4.31 billion; its shares were traded at around $30.92 with a P/E ratio of 5.7 and P/S ratio of 3.6.
On Feb 25, Plains Exploration & Production Company announced 2009 fourth quarter and full-year financial and operating results. For the fourth quarter, revenues of $367.7 million generated $48.1 million of net income, or $0.34 per diluted share. These results include certain items affecting comparability of operating results. Those items consist of realized and unrealized gains and losses on our mark-to-market derivative contracts and other items. When considering these items, net income was $192.6 million, or $1.37 per diluted share (a non-GAAP measure).
Plains Exploration & Production Company is owned by three Gurus: George Soros, PRIMECAP Management, and John Keeley.
Last week, Buy:: Chairman of the Board James C Flores bought 200,000 shares of PXP stock. Sell:: VP-Acctg, Controller & CAO Cynthia A Feeback sold 20,000 shares in November.
Cleco Corp. (CNL): Director Richard B Crowell Bought 8,200 Shares
Director of Cleco Corp., Richard B Crowell, bought 8,200 shares on 3/31/10 at an average price of $26.76.
Cleco Corporation holds investments in several subsidiaries, including Utility Group, Cleco Midstream Resources LLC and Utility Construction & Technology Solutions LLC. Cleco Corp. has a market cap of $1.62 billion; its shares were traded at around $26.76 with a P/E ratio of 15.8 and P/S ratio of 1.9. The dividend yield of Cleco Corp. stocks is 3.4%.
Cleco recently reported fourth quarter earnings applicable to common stock of $12.8 million, or $0.21 per diluted share, compared to $13.5 million, or $0.22 per diluted share, for the fourth quarter of 2008. Earnings applicable to common stock for 2009 were $106.3 million, or $1.76 per diluted share, compared to $102.1 million, or $1.70 per diluted share for 2008.
Cleco Corp. is in the portfolios of Kenneth Fisher and John Keeley.
In March, Buy:: Director Richard B Crowell bought 8,200 shares of CNL stock. Buy:: Director Peter M Scott III, Sell:: Sr Vice President George W Bausewine, Sell:: Group Vice President William G Fontenot and Sell:: Vice President Stephen M Carter sold shares last month.
Seattle Genetics Inc. (SGEN): Director Franklin M Berger Bought 11,500 Shares
Director of Seattle Genetics Inc., Franklin M Berger, bought 11,500 shares on 3/30/10 at an average price of $11.98.
Seattle Genetic develops monoclonal antibody-based drugs to treat cancer and related diseases. Seattle Genetics Inc. has a market cap of $1.21 billion; its shares were traded at around $11.98 with and P/S ratio of 23.2. Seattle Genetics Inc. had an annual average earning growth of 3.6% over the past 10 years.
On February 9, Seattle Genetics Inc. reported results for the fourth quarter of 2009. Revenues in the fourth quarter of 2009 were $21.8 million, compared to $10.1 million in the fourth quarter of 2008. For the full year 2009, revenues were $52.0 million, up from $35.2 million for the full year 2008. The increases in revenues were primarily driven by the earned portion of payments received under the company's collaboration with Genentech. Increases in 2009 revenues also reflect amounts earned under the company's new and ongoing ADC collaborations.
Seattle Genetics Inc. is in the portfolio of Jean-marie Eveillard.
Last week, Buy:: Director Franklin M Berger bought 11,500 shares of SGEN stock.
GeoEye Inc. (GEOY): COO William Schuster Bought 2,274 Shares
CEO of GeoEye Inc., William Schuster, bought 2,274 shares on 3/31/10 at an average price of $30.06.
GeoEye Inc is the a commercial satellite imagery company, delivering high-quality & the most accurate imagery & products to better map, measure, monitor & manage the world. Geoeye Inc. has a market cap of $634.3 million; its shares were traded at around $30.06 with a P/E ratio of 19.9 and P/S ratio of 2.3.
On March 10, GeoEye Inc. reported results for the fourth quarter 2009. Total revenues were $73.2 million for the fourth quarter of 2009, an 80.0 percent increase from $40.7 million for the fourth quarter of 2008. Net income for the fourth quarter of 2009 was $11.7 million, or $0.55 per fully diluted share, compared to a net loss of $3.6 million, or a loss of $0.20 per fully diluted share, for the fourth quarter of 2008. The 2009 fourth quarter earnings included a $27.1 million non-recurring pre-tax loss from the early extinguishment of debt and a tax benefit of $27.7 million.
In March, Buy:: COO William Schuster, Buy:: Chief Technology Officer Brian E O'toole, and Buy:: Senior Vice President, Sales Christopher Tully bought shares of GEOY stock. Sell:: Vice President, Int'l Sales Paolo E Colombi sold 1,846 shares in December; Sell:: COO William Schuster sold 8,000 shares of GEOY stock in November.
Director of Tiffany & Co., Lawrence K Fish, bought 4,000 shares during the past week at an average price of $48.25.
Tiffany & Co. operates jewelry and specialty retail stores and manufactures products through its subsidiary corporations. Tiffany & Co. has a market cap of $6 billion; its shares were traded at around $48.25 with a P/E ratio of 23.8 and P/S ratio of 2.2. The dividend yield of Tiffany & Co. stocks is 1.7%. Tiffany & Co. had an annual average earning growth of 6.9% over the past 10 years. GuruFocus rated Tiffany & Co. the business predictability rank of 4-star.
On March 22, Tiffany & Co. reported that worldwide sales rose 17% in its fourth quarter ended January 31, 2010. This increase reflected broad-based growth in the Americas, Asia-Pacific and European regions. Net earnings from continuing operations were $1.09 per diluted share in the quarter. Full year sales declined 5% to $2.7 billion and net earnings from continuing operations increased 15% to $2.12 per diluted share (earnings in both years included nonrecurring charges
Tiffany & Co. is in the portfolios of four Gurus: Kenneth Fisher, Brian Rogers, John Rogers, and Ron Baron.
Last week, Sell:: CHAIRMAN AND CEO Michael Joseph Kowalski sold 100,000 shares of TIF stock. Sell:: EXEC. VICE PRESIDENT AND CFO James N Fernandez sold shares in January. Last week, Buy:: Director Lawrence K Fish bought 2,000 shares; Sell:: SENIOR VICE PRESIDENT John S Petterson, Sell:: SENIOR VICE PRESIDENT Patrick B Dorsey, and Sell:: SENIOR VICE PRESIDENT Caroline D Naggiar sold shares in March.
Plains Exploration & Production Company (PXP): Chairman of the Board James C Flores Bought 200,000 Shares
Chairman of the Board of Plains Exploration & Production Company, James C Flores, bought 200,000 shares on 3/31/10 at an average price of $30.92.
Plains Exploration & Production Company is an independent oil and gas company primarily engaged in the activities of acquiring, developing, exploring and producing oil and gas properties primarily in the United States. Plains Exploration & Production Company has a market cap of $4.31 billion; its shares were traded at around $30.92 with a P/E ratio of 5.7 and P/S ratio of 3.6.
On Feb 25, Plains Exploration & Production Company announced 2009 fourth quarter and full-year financial and operating results. For the fourth quarter, revenues of $367.7 million generated $48.1 million of net income, or $0.34 per diluted share. These results include certain items affecting comparability of operating results. Those items consist of realized and unrealized gains and losses on our mark-to-market derivative contracts and other items. When considering these items, net income was $192.6 million, or $1.37 per diluted share (a non-GAAP measure).
Plains Exploration & Production Company is owned by three Gurus: George Soros, PRIMECAP Management, and John Keeley.
Last week, Buy:: Chairman of the Board James C Flores bought 200,000 shares of PXP stock. Sell:: VP-Acctg, Controller & CAO Cynthia A Feeback sold 20,000 shares in November.
Cleco Corp. (CNL): Director Richard B Crowell Bought 8,200 Shares
Director of Cleco Corp., Richard B Crowell, bought 8,200 shares on 3/31/10 at an average price of $26.76.
Cleco Corporation holds investments in several subsidiaries, including Utility Group, Cleco Midstream Resources LLC and Utility Construction & Technology Solutions LLC. Cleco Corp. has a market cap of $1.62 billion; its shares were traded at around $26.76 with a P/E ratio of 15.8 and P/S ratio of 1.9. The dividend yield of Cleco Corp. stocks is 3.4%.
Cleco recently reported fourth quarter earnings applicable to common stock of $12.8 million, or $0.21 per diluted share, compared to $13.5 million, or $0.22 per diluted share, for the fourth quarter of 2008. Earnings applicable to common stock for 2009 were $106.3 million, or $1.76 per diluted share, compared to $102.1 million, or $1.70 per diluted share for 2008.
Cleco Corp. is in the portfolios of Kenneth Fisher and John Keeley.
In March, Buy:: Director Richard B Crowell bought 8,200 shares of CNL stock. Buy:: Director Peter M Scott III, Sell:: Sr Vice President George W Bausewine, Sell:: Group Vice President William G Fontenot and Sell:: Vice President Stephen M Carter sold shares last month.
Seattle Genetics Inc. (SGEN): Director Franklin M Berger Bought 11,500 Shares
Director of Seattle Genetics Inc., Franklin M Berger, bought 11,500 shares on 3/30/10 at an average price of $11.98.
Seattle Genetic develops monoclonal antibody-based drugs to treat cancer and related diseases. Seattle Genetics Inc. has a market cap of $1.21 billion; its shares were traded at around $11.98 with and P/S ratio of 23.2. Seattle Genetics Inc. had an annual average earning growth of 3.6% over the past 10 years.
On February 9, Seattle Genetics Inc. reported results for the fourth quarter of 2009. Revenues in the fourth quarter of 2009 were $21.8 million, compared to $10.1 million in the fourth quarter of 2008. For the full year 2009, revenues were $52.0 million, up from $35.2 million for the full year 2008. The increases in revenues were primarily driven by the earned portion of payments received under the company's collaboration with Genentech. Increases in 2009 revenues also reflect amounts earned under the company's new and ongoing ADC collaborations.
Seattle Genetics Inc. is in the portfolio of Jean-marie Eveillard.
Last week, Buy:: Director Franklin M Berger bought 11,500 shares of SGEN stock.
GeoEye Inc. (GEOY): COO William Schuster Bought 2,274 Shares
CEO of GeoEye Inc., William Schuster, bought 2,274 shares on 3/31/10 at an average price of $30.06.
GeoEye Inc is the a commercial satellite imagery company, delivering high-quality & the most accurate imagery & products to better map, measure, monitor & manage the world. Geoeye Inc. has a market cap of $634.3 million; its shares were traded at around $30.06 with a P/E ratio of 19.9 and P/S ratio of 2.3.
On March 10, GeoEye Inc. reported results for the fourth quarter 2009. Total revenues were $73.2 million for the fourth quarter of 2009, an 80.0 percent increase from $40.7 million for the fourth quarter of 2008. Net income for the fourth quarter of 2009 was $11.7 million, or $0.55 per fully diluted share, compared to a net loss of $3.6 million, or a loss of $0.20 per fully diluted share, for the fourth quarter of 2008. The 2009 fourth quarter earnings included a $27.1 million non-recurring pre-tax loss from the early extinguishment of debt and a tax benefit of $27.7 million.
In March, Buy:: COO William Schuster, Buy:: Chief Technology Officer Brian E O'toole, and Buy:: Senior Vice President, Sales Christopher Tully bought shares of GEOY stock. Sell:: Vice President, Int'l Sales Paolo E Colombi sold 1,846 shares in December; Sell:: COO William Schuster sold 8,000 shares of GEOY stock in November.
